MMedication Read More Semaglutide mkt settles into steady growth six months after patent expiry | Industry NewsOctober 14, 2026 Six months after semaglutide lost patent protection in India, generic brands account for about 74 per cent of…
MMedication Read More Generic Ozempic, Mounjaro and GLP-1 market in India: why tirzepatide still leadsSeptember 11, 2026 When cheaper generic versions of semaglutide – originally developed by Danish drugmaker Novo Nordisk and runaway success under…
MMedication Read More Canada approves 2nd generic version of semaglutide – NationalMay 8, 2026 The second generic version of semaglutide — the medication in brand-name drugs like Ozempic and Wegovy — has been…